LATTICE SEMICONDUCTOR CORP
For the period ended Sep 27, 2025. Filed Nov 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 27, 2025 · Filed Nov 3, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements (unaudited)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note1 - Basis of Presentation
Lattice Semiconductor Corporation and its subsidiaries (“Lattice,” the “Company,” “we,” “us,” or “our”) develop technologies that we monetize through differentiated programmable logic semiconductor products, silicon-enabling products, system solutions, design services, and technology licenses.
Basis of Presentation and Use of Estimates
The accompanying Consolidated Financial Statements are unaudited and have been prepared in accordance with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). In our opinion, they include all adjustments, consisting only of normal recurring adjustments, necessary for the fair presentation of results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These Consolidated Financial Statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form10-K for the year ended* December 28, 2024 ("*2024 10-K").
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, the actual results that we experience* may*differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.
We describe our accounting methods and practices in more detail in our2024 10-K. There have beenno changes to the significant accounting policies, procedures, or general information described in our2024 10-K that have had a material impact on our consolidated condensed financial statements and the accompanying notes. Certain prior year balances have been reclassified to conform to the current year’s presentation.
Fiscal Reporting Periods
We report based on a52 or53-week fiscal year ending on the Saturday closest to* December 31.Our fiscal2025* will be a53-week year and will end on* January 3, 2026,and our fiscal2024* was a52-week year that ended* December 28, 2024.Ourthird* quarter of fiscal2025 andthird quarter of fiscal2024 ended on* September 27, 2025and September 28, 2024*, respectively. All references to quarterly or year-to-date financial results are references to the results for the relevant13-week or39-week fiscal period.
Concentrations of Risk
Potential exposure to concentrations of risk* mayimpact revenue and trade accounts receivable. Sales to distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was 83% and 95% for thethird* quarters of fiscal2025 and2024, respectively and 82% and 91% for thefirst nine months of fiscal2025 and2024, respectively. Distributors also account for a substantial portion of our net accounts receivable. At* September 27, 2025*, ourtwo largest distributors accounted for 52% and 35% of net accounts receivable, and at* December 28, 2024*, ourtwo largest distributors accounted for 45% and 36% of net accounts receivable.
New Accounting Pronouncements
In* December 2023,the FASB issued ASU2023*-09, Income Taxes (Topic740*) Improvements to Income Tax Disclosures*, which require greater disaggregation of income tax disclosures. ASU2023-09 aims to improve an entity’s income tax disclosures around its effective rate reconciliation, income taxes paid by jurisdiction, disaggregation of income before income taxes and income tax expense. The guidance in this update is effective for fiscal years beginning after* December 15, 2024,but retrospective application is permitted. Early adoption is permitted. We are currently evaluating the future effect of the adoption of this ASU will have on our consolidated financial statements and disclosures, and donot* expect it will have a material impact on our consolidated results.
-10 -
In* November 2024,the FASB issued ASU2024*-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic220*-40): Disaggregation of Income Statement Expenses*. This new guidance requires public entities to provide disaggregated disclosures, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of income statement. The ASU* maybe applied prospectively or retrospectively and is effective for fiscal years beginning after December 15, 2026and for interim periods beginning after December 15, 2027.*Early adoption is permitted. We are currently evaluating the impact of adoption of this new guidance on our consolidated financial statements and disclosures.
In* September 2025,the FASB issued ASU2025*-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic350*-40): Targeted Improvements to the Accounting for Internal-Use Software*. This ASU is intended to simplify the recognition and disclosure guidance related to capitalized internal-use software costs by removing all references to software development project stages and introducing a more judgment-based framework. ASU2025-06 is effective for fiscal years beginning after* December 15, 2027,and for interim periods within those fiscal years, with early adoption permitted as of the beginning of a fiscal year. This standard may*be applied prospectively, retrospectively, or via a modified prospective transition method. We are currently evaluating the impact of adoption of this new guidance on our consolidated financial statements and disclosures.
Note2 - Net Income per Share
We compute basic earnings per share based on the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period, if applicable. Potentially dilutive shares of common stock from employee equity incentive awards are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding restricted stock units ("RSUs") and restricted stock awards ("RSAs"), and the assumed issuance of common stock under the stock purchase plan.
Our calculation of potentially dilutive shares includes the number of shares from our equity awards with market conditions or performance conditions that would be issuable under the terms of such awards at the end of the reporting period. For equity awards with a market condition, the number of shares included in the diluted share count as of the end of each period presented is determined by measuring the achievement of the market condition as of the end of the respective reporting periods. For equity awards with a performance condition, the number of shares that qualified for vesting as of the end of each period presented are included in the diluted share count when the condition for their issuance was satisfied by the end of the respective reporting periods. See"Note9 - Stock-Based Compensation" to our consolidated financial statements for further discussion of our equity awards with market conditions or performance conditions.
A summary of basic and diluted Net income per share is presented in the following table:
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 27, | September 28, | September 27, | September 28, | |
| (In thousands, except per share data) | 2025 | 2024 | 2025 | 2024 |
| Net income | $2,794 | $7,190 | $10,729 | $44,617 |
| Shares used in basic Net income per share | 136,877 | 137,709 | 137,224 | 137,577 |
| Dilutive effect of employee equity incentive awards | 1,226 | 185 | 845 | 697 |
| Shares used in diluted Net income per share | 138,103 | 137,894 | 138,069 | 138,274 |
| Basic Net income per share | $0.02 | $0.05 | $0.08 | $0.32 |
| Diluted Net income per share | $0.02 | $0.05 | $0.08 | $0.32 |
The computation of diluted Net income per share excludes the effects of employee equity incentive awards that are antidilutive, aggregating approximately 0.7 million and 2.4 million shares for thethird quarters of fiscal2025 and2024, respectively, and approximately 0.9 million and 1.0 million shares for thefirst nine months of fiscal2025 and2024, respectively.
-11 -
Note3 - Revenue from Contracts with Customers
Disaggregation of Revenue
The following tables provide information about revenue from contracts with customers disaggregated by channel and by geographical market, based on ship-to location of our customers:
| Three Months Ended · Nine Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|
| Revenue by Channel · September 27, · September 28, · September 27, · September 28, | ||||||||
| (In thousands) · 2025 · 2024 · 2025 · 2024 | ||||||||
| Distributors | $110,992 | 83% | $120,266 | 95% | $309,339 | 82% | $356,001 | 91% |
| Direct | 22,357 | 17% | 6,825 | 5% | 68,131 | 18% | 35,981 | 9% |
| Total revenue | $133,349 | 100% | $127,091 | 100% | $377,470 | 100% | $391,982 | 100% |
| Revenue by Geographical Market | ||||||||
| (In thousands) | ||||||||
| China | $64,805 | 49% | $49,671 | 39% | $185,636 | 49% | $154,702 | 39% |
| Japan | 7,301 | 5% | 16,633 | 13% | 24,279 | 6% | 64,782 | 17% |
| Other Asia | 14,605 | 11% | 13,508 | 11% | 37,511 | 10% | 35,375 | 9% |
| Asia | 86,711 | 65% | 79,812 | 63% | 247,426 | 65% | 254,859 | 65% |
| Americas | 24,871 | 19% | 19,156 | 15% | 81,751 | 22% | 74,745 | 19% |
| Europe | 21,767 | 16% | 28,123 | 22% | 48,293 | 13% | 62,378 | 16% |
| Total revenue | $133,349 | 100% | $127,091 | 100% | $377,470 | 100% | $391,982 | 100% |
Contract Balances
Our contract assets relate primarily to our rights to consideration for licenses and royalties due to us as a member of the HDMI Founders consortium. The balance results primarily from the amount of estimated revenue related to HDMI that we have recognized to date, but which hasnot yet been distributed to us by the HDMI licensing agent. Contract assets are included in Prepaid expenses and other current assets on our Consolidated Balance Sheets. The following table summarizes activity during thefirst**nine months of fiscal2025:
| (In thousands) | |
|---|---|
| Contract assets as of December 28, 2024 | $17,878 |
| Revenues recorded during the period | 20,138 |
| Transferred to Accounts receivable or collected | (30,640) |
| Contract assets as of September 27, 2025 | $7,376 |
Contract liabilities are included in Accrued liabilities on our Consolidated Balance Sheets. The following table summarizes activity during thefirst**nine months of fiscal2025:
| (In thousands) | |
|---|---|
| Contract liabilities as of December 28, 2024 | $11,182 |
| Revenue recognized from satisfied performance obligations | (6,469) |
| Unperformed performance obligations | 1,129 |
| Accruals for estimated future stock rotation and scrap returns | 4,853 |
| Less: Release of accruals for recognized stock rotation and scrap returns | (4,688) |
| Contract liabilities as of September 27, 2025 | $6,007 |
-12 -
Note4 - Balance Sheet Components
Accounts Receivable
Accounts receivable donot bear interest and are shown net of an allowance for expected lifetime credit losses, which reflects our best estimate of probable losses inherent in the accounts receivable balance, as described in our2024 10-K.
| September 27, | December 28, | |
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Accounts receivable | $95,492 | $81,060 |
| Less: Allowance for credit losses | — | — |
| Accounts receivable, net | $95,492 | $81,060 |
Inventories
| September 27, | December 28, | |
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Work in progress | $74,392 | $82,273 |
| Finished goods | 16,324 | 21,137 |
| Total inventories, net | $90,716 | $103,410 |
Property and Equipment – Geographic Information
Our Property and equipment, net by country at the end of each period was as follows:
| September 27, | December 28, | |
|---|---|---|
| (In thousands) | 2025 | 2024 |
| United States | $40,169 | $26,578 |
| Taiwan | 9,422 | 11,234 |
| Philippines | 6,652 | 6,086 |
| India | 9,514 | 2,165 |
| China | 2,753 | 2,504 |
| Other | 3,622 | 4,421 |
| Total foreign property and equipment, net | 31,963 | 26,410 |
| Total property and equipment, net | $72,132 | $52,988 |
Accrued Liabilities
Included in Accrued liabilities in the Consolidated Balance Sheets are the following balances:
| September 27, | December 28, | |
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Current portion of liability for non-cancelable contracts | $12,150 | $13,534 |
| Contract liabilities | 6,007 | 11,182 |
| Liability for expiring production materials | 1,998 | 7,019 |
| Current portion of operating lease liabilities | 5,805 | 5,818 |
| Other accrued liabilities | 6,126 | 8,085 |
| Total accrued liabilities | $32,086 | $45,638 |
Other Long-Term Liabilities
Included in Other long-term liabilities in the Consolidated Balance Sheets are the following balances:
| September 27, | December 28, | |
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Long-term portion of liability for non-cancelable contracts | $11,410 | $16,022 |
| Other long-term liabilities | 6,191 | 7,894 |
| Total other long-term liabilities | $17,601 | $23,916 |
-13 -
Note5 - Long-Term Debt
On* September 1, 2022,we entered into an Amended and Restated Credit Agreement (the“2022* Credit Agreement”), which provides for afive-year secured revolving loan facility with an aggregate principal amount of up to $350 million.
The revolving loans under the2022 Credit Agreement* maybe repaid and reborrowed at our discretion, with any remaining outstanding principal amount due and payable on the maturity date of the revolving loan on September 1, 2027.At September 27, 2025* and* December 28, 2024*, we hadno borrowings outstanding under the2022 Credit Agreement. We pay a quarterly commitment fee of 0.20% on the unused portion of the revolving facility.
Note6 - Restructuring
Under theQ3 2024 Plan, which is described in our2024 10-K, we incurred restructuring costs of approximately $0.8 million and $2.4 million in thethird quarter andfirst nine months, respectively, of fiscal2025, and approximately $6.5 million in both thethird quarter andfirst nine months of fiscal2024. Under this plan, approximately $10.0 million of total costs have been incurred through* September 27, 2025.TheQ3* 2024 Plan is expected to be largely complete by the end of fiscal year2025.
Under theQ3 2023 Plan, which is described in our2024 10-K, we incurredno restructuring costs during thefirst nine months of fiscal2025, and restructuring costs of approximately $0.3 million and $5.3 million during thethird quarter andfirst nine months, respectively, of fiscal2024. Under this plan, approximately $7.3 million of total costs have been incurred through* September 27, 2025.All actions planned under theQ3* 2023 Plan have been implemented.
Other restructuring activity in the periods presented consisted of expense adjustments on previous plans. Costs and adjustments on restructuring plans are recorded to Restructuring and other on our Consolidated Statements of Operations. The restructuring accrual balance is presented in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets. The following table displays the activity related to our restructuring plans:
| (In thousands) | Severance & Related | Lease Termination & Fixed Assets | Other (1) | Total |
|---|---|---|---|---|
| Accrued Restructuring at December 28, 2024 | $1,905 | $2,964 | $— | $4,869 |
| Restructuring | 2,418 | 40 | — | 2,458 |
| Costs paid or otherwise settled | (3,597) | (1,310) | — | (4,907) |
| Accrued Restructuring at September 27, 2025 | $726 | $1,694 | $— | $2,420 |
| Accrued Restructuring at December 30, 2023 | $1,490 | $4,508 | $620 | $6,618 |
| Restructuring | 11,851 | (49) | (620) | 11,182 |
| Costs paid or otherwise settled | (4,012) | (1,094) | — | (5,106) |
| Accrued Restructuring at September 28, 2024 | $9,329 | $3,365 | $— | $12,694 |
| (1) | Includes termination fees on the cancellation of certain contracts |
Note7 - Leases
We have operating leases for corporate offices, sales offices, research and development facilities, storage facilities, and a data center. All of our facilities are leased under operating leases, which expire at various times through2035, with a weighted-average remaining lease term of 5.2 years and a weighted-average discount rate of 5.6% as of* September 27, 2025*.
We recorded fixed operating lease expenses of $1.7 million and $2.1 million for thethird quarter of fiscal2025 and2024, respectively, and $6.1 million and $6.4 million for thefirst nine months of fiscal2025 and2024, respectively.
The following table presents the lease balance classifications within the Consolidated Balance Sheets and summarizes their activity during thefirst nine months of fiscal2025:
| Operating lease right-of-use assets · (In thousands) | |
|---|---|
| Balance as of December 28, 2024 | $13,870 |
| Right-of-use assets obtained for new lease contracts during the period | 10,349 |
| Amortization of right-of-use assets during the period | (5,240) |
| Adjustments for present value and foreign currency effects | (14) |
| Balance as of September 27, 2025 | $18,965 |
-14 -
| Operating lease liabilities · (In thousands) | |
|---|---|
| Balance as of December 28, 2024 | $15,251 |
| Lease liabilities accrued for new lease contracts during the period | 10,349 |
| Accretion of lease liabilities | 850 |
| Operating cash used for payments on lease liabilities | (5,971) |
| Adjustments for present value and foreign currency effects | (97) |
| Balance as of September 27, 2025 | 20,382 |
| Less: Current portion of operating lease liabilities (included in Accrued liabilities) | (5,805) |
| Long-term operating lease liabilities, net of current portion | $14,577 |
Maturities of operating lease liabilities as of* September 27, 2025* are as follows:
| Fiscal year | (In thousands) |
|---|---|
| 2025 (Remaining quarter) | $1,478 |
| 2026 | 6,550 |
| 2027 | 4,774 |
| 2028 | 3,678 |
| 2029 | 1,493 |
| Thereafter | 5,647 |
| Total lease payments | 23,620 |
| Less: amount representing interest | (3,238) |
| Total lease liabilities | $20,382 |
Lease obligations for facilities restructured prior to the adoption of Topic842 totaled approximately$1.7 million at* September 27, 2025* and is recorded in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets.
Note8 - Intangible Assets
In connection with our past acquisitions and purchases of certain intellectual property assets, we have recorded identifiable intangible assets. We also enter into license agreements forthird-party technology and record them as intangible assets. These licenses are being amortized to Research and development expense over their estimated useful lives. On our Consolidated Balance Sheets at* September 27, 2025* and* December 28, 2024*, Intangible assets, net are shown net of accumulated amortization of $165.2 million and $163.5 million, respectively.
We recorded amortization expense related to intangible assets on the Consolidated Statements of Operations as presented in the following table:
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 27, | September 28, | September 27, | September 28, | |
| (In thousands) | 2025 | 2024 | 2025 | 2024 |
| Research and development | $577 | $299 | $1,626 | $812 |
| Amortization of acquired intangible assets | 20 | 870 | 33 | 2,609 |
| $597 | $1,169 | $1,659 | $3,421 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.